March 24 (Reuters) - Cephalon Inc:
* Wins fentora patent suit against Watson
* Says U.S. court in Delaware found that Watson pharmaceuticals' proposed
generic version of fentora infringes that patent
* Says court also denied watson's motion to vacate a previously entered
injunction preventing Watson from marketing its product
((New York Equities Desk; tel: +1 646 223 6000))
(For more news about Cephalon Inc click here:) COPYRIGHT Copyright Thomson Reuters 2011. All rights reserved. The copying, republication or redistribution of Reuters News Content, including by framing or similar means, is expressly prohibited without the prior written consent of Thomson Reuters.
* Wins fentora patent suit against Watson
* Says U.S. court in Delaware found that Watson pharmaceuticals' proposed
generic version of fentora infringes that patent
* Says court also denied watson's motion to vacate a previously entered
injunction preventing Watson from marketing its product
((New York Equities Desk; tel: +1 646 223 6000))
(For more news about Cephalon Inc click here:) COPYRIGHT Copyright Thomson Reuters 2011. All rights reserved. The copying, republication or redistribution of Reuters News Content, including by framing or similar means, is expressly prohibited without the prior written consent of Thomson Reuters.
© 2011 AFX News
